Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.8 AUD | -5.08% | -29.65% | -34.73% |
Apr. 17 | Wilsons Downgrades Avita Medical to Market-Weight From Overweight; Price Target is AU$3.03 | MT |
Apr. 11 | BTIG Research Downgrades Avita Medical to Neutral From Buy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.69% | 41.35B | |
+42.15% | 40.38B | |
+3.17% | 39.05B | |
-12.11% | 26.67B | |
+1.87% | 24.07B | |
-23.74% | 18.36B | |
-3.67% | 11.68B | |
+21.18% | 11.6B | |
+7.45% | 11.15B |
- Stock Market
- Equities
- RCEL Stock
- AVH Stock
- News AVITA Medical, Inc.
- Avita Medical Establishes Proof of Concept for Cell-based Gene Therapy Treatments